Ocular Therapeutix, Inc.
OCUL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69,418 | -$67,814 | -$64,053 | -$48,388 |
| Dep. & Amort. | $1,072 | $1,026 | $981 | $951 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9,678 | $10,456 | $7,197 |
| Change in WC | $3,728 | $552 | $5,531 | $858 |
| Other Non-Cash | $13,893 | $1,320 | $2,414 | -$47 |
| Operating Cash Flow | -$50,725 | -$55,238 | -$44,671 | -$39,429 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,993 | -$1,245 | -$1,933 | -$202 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $130 | $0 | $0 |
| Investing Cash Flow | -$5,993 | -$1,115 | -$1,933 | -$202 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10,356 | $97,806 | $0 | $524 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $4,183 | $3,989 |
| Financing Cash Flow | $10,356 | $97,806 | $4,183 | $4,513 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$46,362 | $41,453 | -$42,421 | -$35,118 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $391,134 | $351,295 | $393,716 | $428,834 |
| End Cash | $344,772 | $392,748 | $351,295 | $393,716 |
| Free Cash Flow | -$56,718 | -$56,483 | -$46,604 | -$39,631 |